PLASMA-CONCENTRATIONS OF ATRIAL NATRIURETIC PEPTIDE, ARGININE VASOPRESSIN AND HORMONES OF THE RENIN-ANGIOTENSIN SYSTEM IN PATIENTS WITH END-STAGE RENAL-DISEASE

被引：12
|
作者：
ELIAS, AN
VAZIRI, ND
PANDIAN, MR
KAUPKE, J
机构：
来源：
INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS | 1989年 / 12卷 / 03期
关键词：
D O I：
10.1177/039139888901200304
中图分类号：
R318 [生物医学工程];
学科分类号：
0831 ;
摘要：
引用
收藏
页码：153 / 158
页数：6
相关论文
共 50 条
  • [21] Circulating natriuretic peptide concentrations in patients with end-stage renal disease: Role of brain natriuretic peptide as a biomarker for ventricular remodeling
    Cataliotti, A
    Malatino, LS
    Jougasaki, M
    Zoccali, C
    Castellino, P
    Giacone, G
    Bellanuova, I
    Tripepi, R
    Seminara, G
    Parlongo, S
    Stancanelli, B
    Bonanno, G
    Fatuzzo, P
    Rapisarda, F
    Belluardo, P
    Signorelli, SS
    Heublein, DM
    Lainchbury, JG
    Leskinen, HK
    Bailey, KR
    Redfield, MM
    Burnett, JC
    MAYO CLINIC PROCEEDINGS, 2001, 76 (11) : 1111 - 1119
  • [22] INFLUENCE OF DIALYSIS MODALITY ON PLASMA AND TISSUE CONCENTRATIONS OF PENTOSIDINE IN PATIENTS WITH END-STAGE RENAL-DISEASE
    FRIEDLANDER, MA
    WU, YC
    SCHULAK, JA
    MONNIER, VM
    HRICIK, DE
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1995, 25 (03) : 445 - 451
  • [23] Altered regulation of renal interstitial hydrostatic pressure and the renal renin-angiotensin system in the absence of atrial natriuretic peptide
    O'Tierney, Perrie F.
    Komolova, Marina
    Tse, M. Yat
    Adams, Michael A.
    Pang, Stephen C.
    JOURNAL OF HYPERTENSION, 2008, 26 (02) : 303 - 311
  • [24] PHYSIOLOGIC CONCENTRATIONS OF ATRIAL NATRIURETIC FACTOR INHIBIT ACTIVATION OF THE RENIN-ANGIOTENSIN SYSTEM DURING RENAL HYPOTENSION
    MILLER, WL
    AARHUS, LL
    HEUBLEIN, DM
    BURNETT, JC
    CLINICAL RESEARCH, 1988, 36 (06): : A890 - A890
  • [25] Effects of Renin-Angiotensin-Aldosterone System Blaockade in Patients with End-Stage Renal Disease
    Slomka, Teresa
    Lennon, Emily S.
    Akbar, Hina
    Gosmanova, Elvira O.
    Bhattacharya, Syamal K.
    Oliphant, Carrie S.
    Khouzam, Rami N.
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2016, 351 (03): : 309 - 316
  • [26] IS RENIN ANGIOTENSIN SYSTEM MODULATION BENEFICIAL IN HEART FAILURE PATIENTS WITH END-STAGE RENAL DISEASE
    Saad, Muhammad
    Ashraf, Shoaib
    Prakash, Upreti
    Shrestha, Nikee
    Kulshrestha, Sarthak
    Hassan, Muhammad
    Bing, Yue
    Tang, Haiming
    Vittorio, Timothy J.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (18) : 698 - 698
  • [27] INCREASED PLASMA LIPOPROTEIN(A) LEVELS IN PATIENTS WITH END-STAGE RENAL-DISEASE
    DIEPLINGER, H
    LACKNER, C
    KONIG, P
    UTERMANN, G
    ARTERIOSCLEROSIS, 1990, 10 (05): : A860 - A860
  • [28] GENTAMICIN CONCENTRATIONS IN BLOOD, URINE, AND RENAL TISSUE OF PATIENTS WITH END-STAGE RENAL-DISEASE
    BENNETT, WM
    HARTNETT, MN
    CRAVEN, R
    GILBERT, DN
    PORTER, GA
    JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1977, 90 (02): : 389 - 392
  • [29] Atrial natriuretic peptide and arginine-vasopressin secretion in patients with active renal stone disease
    Kokot F.
    Klimek D.
    Wiȩcek A.
    Kuczera M.
    International Urology and Nephrology, 1998, 30 (3) : 357 - 365
  • [30] PLASMA-RENIN ACTIVITY AND TOTAL PERIPHERAL RESISTANCE IN CHRONIC END-STAGE RENAL-DISEASE
    SKRABAL, F
    AIGNER, A
    DITTRICH, P
    WIENER KLINISCHE WOCHENSCHRIFT, 1974, 86 (19) : 564 - 566
12345